NO179602C - Anvendelse av et NADH eller NADPH ved fremstilling av et antidepresjonsmiddel - Google Patents

Anvendelse av et NADH eller NADPH ved fremstilling av et antidepresjonsmiddel

Info

Publication number
NO179602C
NO179602C NO920056A NO920056A NO179602C NO 179602 C NO179602 C NO 179602C NO 920056 A NO920056 A NO 920056A NO 920056 A NO920056 A NO 920056A NO 179602 C NO179602 C NO 179602C
Authority
NO
Norway
Prior art keywords
antidepressant
nadh
nadph
preparation
adenine dinucleotide
Prior art date
Application number
NO920056A
Other languages
English (en)
Norwegian (no)
Other versions
NO179602B (no
NO920056D0 (no
NO920056L (no
Inventor
Jorg Birkmayer
Walter Birkmayer
Original Assignee
Birkmayer Joerg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birkmayer Joerg filed Critical Birkmayer Joerg
Publication of NO920056D0 publication Critical patent/NO920056D0/no
Publication of NO920056L publication Critical patent/NO920056L/no
Publication of NO179602B publication Critical patent/NO179602B/no
Publication of NO179602C publication Critical patent/NO179602C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO920056A 1991-01-04 1992-01-03 Anvendelse av et NADH eller NADPH ved fremstilling av et antidepresjonsmiddel NO179602C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4100361A DE4100361C1 (pt) 1991-01-04 1991-01-04

Publications (4)

Publication Number Publication Date
NO920056D0 NO920056D0 (no) 1992-01-03
NO920056L NO920056L (no) 1992-07-06
NO179602B NO179602B (no) 1996-08-05
NO179602C true NO179602C (no) 1996-11-13

Family

ID=6422686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920056A NO179602C (no) 1991-01-04 1992-01-03 Anvendelse av et NADH eller NADPH ved fremstilling av et antidepresjonsmiddel

Country Status (15)

Country Link
EP (1) EP0493861B1 (pt)
JP (1) JP2519148B2 (pt)
AT (1) ATE148991T1 (pt)
AU (1) AU631755B2 (pt)
BR (1) BR9105183A (pt)
CA (1) CA2057456C (pt)
DE (2) DE4100361C1 (pt)
DK (1) DK0493861T3 (pt)
ES (1) ES2097181T3 (pt)
GR (1) GR3022724T3 (pt)
HU (1) HU213112B (pt)
IE (1) IE914477A1 (pt)
NO (1) NO179602C (pt)
PT (1) PT99962B (pt)
ZA (1) ZA9244B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2167104A1 (en) * 1995-01-17 1996-07-18 Joerg G.D. Birkmayer Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
ES2953842A1 (es) * 2023-07-17 2023-11-16 Nuadi Europe S L Tapacubos antipolvo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341412A (en) * 1966-03-04 1967-09-12 Enzomedic Lab Inc Methods of treating schizophrenia
US4970200A (en) * 1988-03-01 1990-11-13 Schering Aktiengesellschaft Agent for treatment of Parkinson's disease

Also Published As

Publication number Publication date
HU213112B (en) 1997-02-28
HU9200025D0 (en) 1992-03-30
EP0493861A3 (en) 1993-03-03
DE59108553D1 (de) 1997-03-27
GR3022724T3 (en) 1997-06-30
CA2057456C (en) 1996-02-06
ATE148991T1 (de) 1997-03-15
DE4100361C1 (pt) 1992-04-23
PT99962A (pt) 1993-02-26
JP2519148B2 (ja) 1996-07-31
BR9105183A (pt) 1992-09-29
EP0493861A2 (de) 1992-07-08
AU9010991A (en) 1992-07-16
EP0493861B1 (de) 1997-02-19
AU631755B2 (en) 1992-12-03
HUT60141A (en) 1992-08-28
ES2097181T3 (es) 1997-04-01
NO179602B (no) 1996-08-05
ZA9244B (en) 1992-10-28
PT99962B (pt) 1999-06-30
NO920056D0 (no) 1992-01-03
DK0493861T3 (da) 1997-08-25
JPH05139978A (ja) 1993-06-08
CA2057456A1 (en) 1992-07-05
NO920056L (no) 1992-07-06
IE914477A1 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
DK0697859T3 (da) Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPH
AU674463B2 (en) Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
NO933321D0 (no) Nadh og nadph som legemiddel til behandling av mobus alzheimer
GB2204415B (en) Amperometric method for the quantitative determination of 1,4 dihydronicotinamide adenine dinucleotide (nadh) and its phosphorylated derivative in solution.
EP0345248A3 (de) Verwendung des Enzym-Cofaktors NADPH zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
NO179602C (no) Anvendelse av et NADH eller NADPH ved fremstilling av et antidepresjonsmiddel
FI920323A (fi) Nadh och nadph som energisubstitut.
NO923324D0 (no) Medikament mot kreft eller aids

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JULY 2003